Michael Rebhan

Institution: NIBR


Novartis Campus, Fab22.4, 4058 Basel

Email: michael.rebhan@novartis.com

Group website: www.nibr.com

Research interests:

new paradigms in Precision Medicine, multi-modal biomarkers to healthcare decisions, observational clinical studies for biomarker discovery

Selected publications:

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M. (2013) Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E1026-34. PMID: 23431153
Lewitter F1, Rebhan M. (2009) Establishing a successful bioinformatics core facility team. PLoS Comput Biol. 2009 Jun;5(6). PMID: 19557124
Weber M1, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, Schübeler D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007 Apr;39(4):457-66. PMID: 17334365
Rebhan M1, Chalifa-Caspi V, Prilusky J, Lancet D. (1998) GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics. 1998;14(8):656-64. PMID: 9789091
Rösner H1, Rebhan M, Vacun G, Vanmechelen E. (1995) Developmental expression of tau proteins in the chicken and rat brain: rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms.Int J Dev Neurosci. 1995 Oct;13(6):607-17

Members List